Healthwise
To print: Use your web browser's print feature. Close this window after printing.

Cirrhosis: Beta-Blockers for Portal Hypertension and Varices

Table of Contents


Overview

Beta-blocker medicines are used to prevent an episode of variceal bleeding by lowering the blood pressure in the enlarged veins (varices). Variceal bleeding occurs when the blood pressure increases in the portal vein system and the veins in the esophagus, stomach, and rectum enlarge to accommodate blocked blood flow through the liver.

By slowing the heart rate and widening the blood vessels, beta-blocker medicines such as propranolol and nadolol appear to lower the blood pressure in varices that bypass the liver. In people who have esophageal varices, beta-blockers have been shown to reduce the risk of having a first episode of bleeding.1 They are usually prescribed for people who have moderate-to-large varices.


References

Citations

  1. Garcia-Tsao G, et al. (2007). Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology, 102(9): 2086–2102.

Credits for Cirrhosis: Beta-Blockers for Portal Hypertension and Varices

Current as of: June 6, 2022

Author: Healthwise Staff
Medical Review:
Adam Husney MD - Family Medicine
W. Thomas London MD - Hepatology


Note: The "printer friendly" document will not contain all the information available in the online document. Some information (e.g. cross-references to other topics, definitions or medical illustrations) is only available in the online version.

© 1995-2022 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information.